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ABSTRACT
Clinical research conducted to Good Clinical Practice (GCP) 
standards is increasingly being undertaken in resource- 
constrained low- income and middle- income countries 
(LMICs) settings. This presents unique challenges that 
differ from those faced in high- income country (HIC) 
contexts, due to a dearth of infrastructure and unique 
socio- cultural contexts. Field experiences by research 
teams working in these LMIC contexts are thus critical 
to advancing knowledge on successful research conduct 
in these settings. The Medical Research Council Unit The 
Gambia at London School of Hygiene and Tropical Medicine 
has operated in The Gambia, a resource- constrained 
LMIC for over 70 years and has developed numerous 
research support platforms and systems. The unit was 
the lead clinical collaborator in a recently completed 
Expanded Program on Immunization Consortium (EPIC) 
study, involving a multicountry collaboration across five 
countries including the USA, Canada, Belgium, Papua New 
Guinea and The Gambia. The EPIC study recruited and 
completed follow- up of 720 newborn infants over 2 years. 
In this paper, we provide in- depth field experience covering 
challenges faced by the Gambian EPIC team in the conduct 
of this study. We also detail some reflections on these 
challenges. Our findings are relevant to the international 
research community as they highlight practical day- to- day 
challenges in conducting GCP standard clinical research 
in resource- constrained LMIC contexts. They also provide 
insights on how study processes can be adapted early 
during research planning to mitigate challenges.
BACKGROUND
Clinical research undertaken to interna-
tionally recognised standards is increasingly 
being conducted in resource- constrained 
low- income and middle- income countries 
(LMICs). This is in part related to globali-
sation and a skewed distribution in global 
disease burden.1 While high- income countries 
(HICs) comparatively have greater research 
expertise,1 many diseases are more prevalent 
in LMICs, creating an unmet need and obli-
gation for relevant clinical research conduct 
in these settings.2
Despite significant advantages, research 
conducted in LMIC contexts pose different 
challenges than would be expected in HICs. 
Many LMICs are characterised by poverty, 
fragile health systems, political instability 
and frequent policy changes that may impact 
research conduct.3 4 Socio- cultural contexts 
also differ considerably from HICs, and an 
in- depth understanding of their dynamics is 
necessary for research success.5–8 Informa-
tion on key processes to overcome opera-
tional challenges and local field experiences 
are thus critical to advancing knowledge for 
successful research conduct in these settings.
Summary box
 ► Globalisation has led to an increase in clinical re-
search conducted to internationally recognised stan-
dards in many resource- constrained low- income 
and middle- income (LMIC) settings.
 ► LMIC research contexts differ significantly from 
those of high- income countries and field experienc-
es of research teams operating in these areas are 
crucial to providing insights into the successful con-
duct of research in these regions.
 ► We present field operational challenges and how we 
navigated them during the conduct of a study in The 
Gambia.
 ► Our experience shows that highly supportive re-
search platforms, flexibility, proactivity and working 
collaboratively with in- country governments and 
communities are crucial to the successful conduct 
of research in such settings.
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The Medical Research Council (MRC) Unit The 
Gambia at London School of Hygiene and Tropical Medi-
cine (henceforth, MRCG at LSHTM) was the lead clinical 
collaborator in a recently completed Expanded Program 
on Immunization Consortium (EPIC) study. The EPIC 
is a multicountry collaboration involving partners from 
the USA, Canada, Belgium and Papua New Guinea.9 The 
study recruited and followed up 720 newborn infants over 
2 years in The Gambia (figure 1); a resource- constrained 
LMIC.9 10
In this paper, we highlight field operational challenges 
faced by the EPIC lead clinical team during our study 
set- up and conduct; and the processes we employed to 
navigate them. Our paper provides research teams plan-
ning to conduct clinical research in resource- constrained 
or LMIC settings with contextual and first- hand field 
experience of common challenges. Such information 
is relevant to help teams adapt their processes early on 
in their research planning, limit setbacks in research 




The Gambia is located in West Africa and has a popula-
tion of about 2.5 million.11 It is a low- income country with 
48.6% of the population living below the national poverty 
line.10 Like many low- income countries, The Gambia 
experiences infrastructural deficits. Its road networks 
are limited and the health system is frequently overbur-
dened.12 13 Healthcare is provided mainly by the govern-
ment and is divided into three tiers—tertiary referral 
hospitals, district level facilities which provide secondary 
care and primary health facilities.12 We recruited our 
participants from two government- owned health facili-
ties, the Banjulinding Health Centre, a primary health-
care facility, and the Kanifing General Hospital which 
offers secondary level care.
MRCG at LSHTM
The MRCG at LSHTM is a leading research institution in 
sub- Saharan Africa, which has been in existence for over 
seven decades providing scientific expertise and high- 
quality research support platforms to facilitate successful 
research. These support platforms include a combination 
of core services and a research services cluster (figure 2). 
The core services include a transport department respon-
sible for managing a vehicle and motorbike fleet; human 
resources, which oversees the recruitment and compen-
sation of staff; logistics, which facilitates the receipt of 
supplies and transportation of goods; and communica-
tions department, which coordinates all the internal and 
external unit correspondences. The research services 
cluster, on the other hand, includes a research support 
office, which guides and supports research management, 
governance and compliance of research projects; a clin-
ical trial support office, which ensures that clinical trials 
implemented at the unit are compliant with international 
best practices; a Biobank, which is the storage manage-
ment system for all biological samples; and the laboratory 
services department who support research activities and 
patient clinical diagnosis.
Brief study context
The EPIC study recruited 720 newborn infants at birth 
and followed up each participant for 5 months to iden-
tify vaccine- induced molecular signatures to characterise 
early- life immune molecular pathways and inform future 
development of vaccines optimised for use in early life.9 
The full research protocol for the study has previously 
been published elsewhere.9 The study recruited newborns 
in the first 24 hours of life and randomly assigned birth 
Expanded Program on Immunization (EPI) vaccines. 
This involved giving either birth dose hepatitis B (HepB) 
or BCG alone, or a combination of both vaccines or no 
vaccines and catch- up of the remaining birth vaccines (to 
include oral polio vaccine) on day 1, 3 or 7 of life with 
subsequent blood draws to identify molecular signatures 
and determine vaccine immunogenicity.
STUDY OPERATIONAL CHALLENGES
The key challenges we experienced during the study are 
grouped into six themes and are summarised in table 1.
Figure 1 Map showing The Gambia in West Africa 
(shapefiles for our map are from https://gadm.org/data.html 
and https://mapchart.net/africa.html). Figure 2 Diagram showing part of the research services 
cluster and core services at the MRC Unit.
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Human resource challenges
Recruiting, following- up, generating credible data and 
ensuring participant safety for 720 newborn infants 
in a resource- constrained LMIC requires a research 
team skilled in providing neonatal care. At the time 
of conducting our study, there was a paucity of human 
resource skilled to provide this level of care in The 
Gambia.
To manage these challenges, the study recruited paedi-
atricians from the West African subregion to support care 
provision for enrolled newborns and step- down newborn 
care training to the clinical team. We also leveraged previ-
ously established partnerships with a UK- based institution 
to provide additional newborn care and infection control 
training for research staff and government facility nurses. 
In keeping with standard MRCG at LSHTM procedures, 
all project staff also benefited from in- house Good Clin-
ical Practice (GCP) research training. All staff received 
training on the study standard operating procedures and 
all initial research activities were performed in groups 
before independent operations commenced. Every 
station was manned by at least two study personnel as an 
additional quality control check allowing staff to double- 
check each step.
Vaccination policy change
Birth doses of EPI vaccine are often delayed until later in 
the newborn period within the Gambia.14 This is partly 
due to the need to prevent vaccine wastages arising 
from opening multidose vials out of hours when deliv-
eries tend to occur and the need to minimise pressure 
on limited ward space necessitating early postpartum 
discharge before routine daytime immunisation clinics. 
It is also common for caregivers to delay vaccine birth 
doses past the baby’s traditional naming rites occurring 
on the seventh day of life.
Midway through the conduct of our study, there was 
an unanticipated change in the Gambian vaccination 
strategy to address birth delays. The government piloted 
in- hospital administration of birth dose vaccination to 
newborns delivered within government hospitals before 
their discharge. This programme covered the main 
government hospitals and included one of the EPIC 
study sites. Its focus was to ensure timely vaccine uptake, 
particularly for HepB vaccine which is crucial for inter-
rupting perinatal transmission of HepB virus (HBV) 
infection, as the local community prevalence of HBV was 
high at 8.8%.14 15
The EPIC study had taken into consideration the local 
HBV infection burden during study design. We performed 
testing for maternal HBV infection before participant 
enrolment and excluded all HBV positive mothers, 
Table 1 Summary of challenges encountered by the Expanded Program on Immunization Consortium team with study 
responses to them
Broad challenges Specific challenges Response
Human resource challenge   Limited in- country specialists.  ► Regional recruitment from the West- 
African subregion.
Vaccination policy change Administration of birth vaccine doses before 
discharge to babies delivered in select government 
hospitals.
 ► Speedily addressed bottleneck with 
government authorities.
Logistic challenges  ► Limited road network.
 ► Lack of a functional house address system.
 ► Shipping of biosamples to northern 
collaborators.
 ► Worked with the Medical Research 
Council unit’s logistic and transport 
system.
Participant recruitment  ► Sensitised participants delivering outside the 
study location.
 ► Competing interest with another study at the 
research site.
 ► Early discharges from labour ward pressures.
 ► Commenced recruitment at an 
additional facility.
 ► Set up a roving team.
 ► Re- organised staff rota to maximise 
recruitments.
Host health facility challenges  ► Space constraints.
 ► Neonatal sepsis outbreak.
 ► Built an office complex for research 
operations.
 ► Capacity building for government 
staff on infection control and 
newborn resuscitation.
 ► Worked with and provided technical 
assistance to host health facility to 
tackle an outbreak.
Rumours and misconceptions Study- related rumours.  ► Community sensitisation.
 ► Prepared communication strategy to 
address rumours.
ICH- GCP - International Conference on Harmonisation- Good Clinical Practice
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immediately vaccinating their newborns according to the 
WHO recommendation to limit the risk of transmission. 
The new vaccination policy meant it would be difficult to 
continue our study which was entirely based on randomly 
staggering birth dose vaccines throughout the first week 
of life in a population carefully screened at enrolment.
The team halted participant recruitment while securing 
a waiver that allowed our recruited participants to be vacci-
nated according to the approved project schedule. This 
process was greatly facilitated by existing links between 
the unit and the government and also our prior ethical 
considerations which ensured that we did not put babies 
at risk of infection by screening out any HepB positive 
mothers and families affected by tuberculosis.
Logistical challenges
Logistical challenges occur with every study and those 
conducted in LMICs experience unique challenges often 
related to a dearth of infrastructure.16 17 The limited 
road network in The Gambia means many feeder roads 
are untarred, which makes it difficult for participants to 
attend follow- up visits. This is particularly during the rains 
when whole communities could be cut- off from the town-
ship. Second, there is a lack of a functional home address 
system within the Gambia and it is common practice to 
reference a participant’s residence using a local tree, or 
a mosque, or the house of a traditional ruler sometimes 
making it inefficient to trace participants, particularly 
in emergencies. Third, even though part of our study 
inclusion criteria was being resident for the subsequent 
6 months within the study area, it was not uncommon 
for the occasional participant to travel during scheduled 
visits.
Additional logistical challenges included the need to 
conduct some of the biological assays outside the Gambia 
due to a lack of facility for certain select assays. Biosamples 
were shipped to specialised laboratories in the USA and 
Canada for analysis. This involved significant paperwork 
and applying for customs clearance, as well as providing 
reliable temperature control and monitoring of biosam-
ples throughout the study and during shipment.
To address these challenges, we relied heavily on the 
MRCG at LSHTM transport system which has a fleet of 
four- wheel drives and motorcycles and has drivers who 
are extremely knowledgeable of the local terrain. We used 
this transport system to drop off and pick up newborn 
infants and their mothers during first- week of life study 
visits which was a vulnerable period for them and also 
for when participants were stranded due to rain or road 
conditions. Additionally, we had fieldworkers allocated to 
participants who accompanied them home alongside our 
project drivers following initial labour ward discharge 
(figure 3). This served to identify the exact participant 
residence and familiarise staff with immediate family 
members. This assigned field assistant also served as a 
focal contact for participant emergency communication 
with the team, such as in the event of illness or sudden 
travel. Our study protocol also included visit windows 
which allowed for some visit flexibility. When participant 
travel occurred outside these windows, we coordinated 
with the country EPI programme to deliver vaccines at 
local clinic outposts.
The team also relied heavily on the established MRCG 
at LSHTM Biobank for initial sample storage and the 
logistics department’s longstanding collaborations with 
local shipping companies. These staff are trained to 
International Air Transport Association standards for 
storing and shipping bio- samples.
Participant recruitment
As with many clinical studies, our initial participant 
recruitment was relatively slow. This was partly by design 
to allow for smooth study protocol operationalisation 
and the development of team cohesion. Our operation 
design included ethical considerations for obtaining valid 
consent from women presenting in labour. We provided 
information to pregnant women in their second and third 
trimesters attending antenatal care at our study sites. 
This allowed women an opportunity to discuss the study 
with other significant decision- makers within the family, 
notably spouses, who are often key decision- makers in 
LMICs.18 Women who expressed interest in participating 
were encouraged to ask questions at a follow- up phone 
call/visit and completed the consent process when they 
presented in labour. However, several sensitised women 
did not deliver at the study site. Unanticipated changes 
to another study at the site meant, our participant pool 
became smaller than previously anticipated. Labour ward 
pressures for space also meant a considerable number 
of potential participants were discharged shortly after 
delivery or overnight before the team arrived for regular 
work hours.
As we largely anticipated these challenges, the team 
commenced recruitment at an additional facility and set 
up a roving recruitment team to recruit sensitised partic-
ipants who delivered at other health facilities. Addition-
ally, we re- organised staff rotas to maximise participant 
recruitment.
Figure 3 Dedicated field staff organising field activities; 
clinical activities going on in the background.
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Host health facility challenges
At the early stages of the study, the EPIC team experi-
enced space constraints on the field. The labour wards 
and delivery rooms were frequently crowded, giving little 
room for research staff to operate. We also experienced 
an outbreak of presumed neonatal sepsis in one of our 
two study sites.
The MRC unit had prior knowledge of space constraints 
within the local health system and had sourced funds 
and commenced building an office complex within the 
health facility. Construction was completed in time to 
ease operations as participant numbers increased. Also, 
with prior knowledge of challenges relating to hospital 
infection control practices in LMICs, the study had 
involved government nurses in hands- on clean delivery 
room practice training and empowered our host health 
facilities to sustain cleaning through periodic supple-
mentation of cleaning agents.
Following a labour ward sepsis outbreak, we worked 
with the local hospital authority to halt deliveries and 
document all neonatal sepsis cases that had occurred in 
the preceding weeks. We then supported the culturing 
of labour ward surfaces and equipment and organised 
the cleaning and disinfection of the facility, working 
together with hospital staff and community volunteers. 
The effect of our cleaning measures resulted in the elimi-
nation of new cases, following which we further modified 
our support strategy by providing manpower support for 
monthly health facility- led cleaning exercises. We also 
developed funding applications to encourage commu-
nity ownership and sustainability.
Rumours and misconceptions
Rumours and misconceptions regarding research activi-
ties are typical for clinical research in varied settings. The 
rumours in resource- constrained settings are often linked 
to community distrust of research teams.19 One way to 
limit such rumours is patient and public involvement 
in all aspects of research, from the design, conduct and 
study reporting. However, in some instances, it might be 
impractical to involve the public across the full research 
cycle. In our case, although patients were not involved 
in our study design, we recognised the challenges with 
community information management in LMIC settings 
and conducted extensive community sensitisation before 
and during the study, and plan post- study contacts. 
This involved multiple meetings and engagement with 
members of our research communities, and their leaders 
locally referred to as ‘Alkalos’ and other key community 
leaders including religious, women group and village 
health community leaders.
Despite these efforts, rumours emanated that we were 
administering placebo to our study participants instead 
of EPI vaccines. For these rumours, we worked closely 
with the unit’s research support office and the communi-
cations department to conduct further host community 
sensitisation. The departments were also prepared to 
engage further and provide facility tours to explain the 
unit’s research.
REFLECTIONS
A dearth of local experts presents a major barrier facing 
research studies conducted in resource- constrained 
LMIC settings.20 In such contexts, the absence of qual-
ified and appropriately trained study personnel could 
result in the collection of poor- quality data or, compro-
mise participant safety. We regularly conduct GCP 
courses that ensure an up- to- date understanding of 
research fundamentals for new study staff and serve as 
refresher training for more established staff. Addition-
ally, our recruitment of regionally- trained specialists 
addresses a local deficit and proffers certain advantages. 
These staff often have prior clinical experience practising 
in resource- constrained settings and provide locally rele-
vant clinical training for their teammates given the simi-
larities in contexts. Other capacity strengthening models 
described elsewhere involves employing local specialists 
on a part- time basis and pairing them with expatriates in 
a symbiotic fashion, where the local staff enhances the 
contextual understanding of the expatriate, who in turn 
supports technical know- how.21
In addition to human resource challenges, infrastruc-
tural deficits are also typical in many LMIC settings and 
both of these can be capital- intensive. Some research proj-
ects in LMIC have provided their own sources of water 
and had to generate their own electricity.21 Pre- empting 
these challenges during the research planning phase 
might mitigate them. For this reason as is common for 
research in this setting budget lines allowing for regional 
recruitment were pre- planned along with leveraging plat-
form resources for a research office. We were able to limit 
other infrastructure- related costs by relying on the unit’s 
research support platforms. An example is our reliance 
on the unit’s transport fleet which charges a fee based on 
kilometres covered by research projects a cheaper alter-
native to acquiring project vehicles. Retaining regionally 
recruited staff on subsequent projects contributes to 
defraying costs associated with staff relocation. Where 
such support does not exist, non- permanent measures 
might serve as cheaper alternatives for the infrastruc-
tural gap. For example, previous studies at the unit have 
operated from modified and reconditioned shipping 
containers or mobile caravan units. Excellent relations 
with host communities have also contributed to tempo-
rary research space requirements.
Research in LMICs are also not immune to changes 
in external policy, as occur in any setting. During the 
conduct of our study, a vaccination policy change had the 
potential to negatively affect our recruitment. We lever-
aged already existing collaborations and communication 
channels between the unit and the Gambian government 
to address this. This highlights how critical it is to have 
the government as a stakeholder and driver of research 
conduct. Aside from limiting the influence of government 
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policy changes on research projects, such collaboration 
creates greater chances of local acceptability and is a crit-
ical first step to stimulating government- led and funded 
research to address relevant LMIC community needs.
Managing host expectations is also important in 
resource- limited LMIC settings. A common narrative is 
that funded research projects have limitless funds and 
this can place such projects in challenging situations with 
impossible demands. It is in instances useful to consider 
written contractual agreements with host health facilities. 
As part of initial meetings with these facilities, bilaterally 
agreeing on the rules of engagement and also services 
and resources the projects can realistically provide is 
critical.
Finally, there is a greater chance of success for studies 
when research facilities possess existing research support 
platforms. Our study greatly benefited from the MRCG at 
LSHTM existing research support platforms and systems 
which greatly facilitated all aspects of our research.
CONCLUSIONS
Conducting clinical research in resource- constrained 
LMIC settings comes with unique challenges. A key to 
successfully conduct research to international stand-
ards requires a thorough understanding of potential 
challenges during planning. These are best highlighted 
by the host institution given the uniqueness of varied 
contexts. These studies also require flexibility, proac-
tivity and working synergistically with study communi-
ties, host institutions and governments to ensure success. 
Additional ingredients for success are well- established 
research support platforms and sensitivity to the local 
traditions. These factors are crucial to consider to create 
viable research hubs that address locally relevant research 
questions and generate credible data acceptable to the 
wider research community.
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